Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery
and hyperthermic intraperitoneal chemotherapy: a single centre experience.
Neoadjuvant chemotherapy (NACT) has emerged as an alternative treatment strategy to primary cytoreductive surgery
. Women treated with NACT typically undergo 3 to 4 cycles of platinum- and taxane-based chemotherapy, receive interval cytoreduction, and then are treated with an additional 3 to 4 cycles of chemotherapy postoperatively.
Patients with normal levels of CA 125 or mild elevated CA 125 levels can be considered for cytoreductive surgery
followed by adjuvant chemotherapies.
in platinum-sensitive recurrent ovarian cancer.
peritoneal mesothelioma and peritoneal pseudomyxoma peritonei) and PC derived from colon or ovarian cancers receive optimal cytoreductive surgery
accompanied by hyperthermic intraperitoneal chemotherapy (HIPEC) with a curative intent with encouraging outcomes.
Eighty-six children and adolescents (median age, 12 years) who had undergone cytoreductive surgery
with hyperthermic intraperitoneal chemotherapy were included.
What is the optimal goal of primary cytoreductive surgery
for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery
and HIPEC: a systematic review of survival, mortality, and morbidity.
A systematic review on the efficacy of cytoreductive surgery
and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
(5) Cytoreductive surgery
for ovarian cancer can be associated with substantial morbidity, and exposing patients to prolonged operative time, extended periods of hyperthermia, and high doses of cytotoxic agents is a concern.
Of the 24 dogs, 15 were treated with radiation therapy and chemotherapy, five with cytoreductive surgery
followed by radiation therapy and chemotherapy, three with palliative radiation therapy alone, and one with radiation therapy associated with one session of electrochemotherapy (performed 60 days after the end of the radiation therapy).
An optimal surgical debulking is advocated for ovarian tumours and chemotherapy with taxol and carboplatin is effective whereas the clinical utility of radical tumour debulking and chemotherapy remains unknown for appendiceal cancers.5,8 However, an aggressive cytoreductive surgery
and a perioperative intraperitoneal chemotherapy with Mitomycin-C and 5-fluorouracil could be used for appendiceal cancers with peritoneal disseminations.5